Qi-Lu Cheng

Title: The Innovative Contributions of Qi-Lu Cheng

Introduction

Qi-Lu Cheng is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit malignant cell growth. His work is crucial in the ongoing fight against various forms of cancer.

Latest Patents

Qi-Lu Cheng holds a patent for the "Use of A-Nor-steroids as malignant cells growth inhibitors." This patent focuses on A-Nor-5.alpha.-androstane compounds, including the dipropionate and disuccinate esters of 2.alpha.,17.alpha.-diethynyl-A-Nor-5.alpha.-androstane-2.beta.,17.beta.-diol and their corresponding 2.alpha.,17.alpha.-diol stereoisomers. These compounds have demonstrated an inhibitory effect on malignant cell growth and can be utilized in treating various carcinomas in mammals. He has 1 patent to his name.

Career Highlights

Qi-Lu Cheng is associated with Natural Pharmacia International, Inc., where he continues to innovate and contribute to the field of cancer treatment. His research and development efforts are aimed at creating effective therapies for patients suffering from cancer.

Collaborations

Some of his notable coworkers include Rui-Lin Li and David Yue-wei Lee. Their collaborative efforts enhance the research environment and contribute to the advancement of their projects.

Conclusion

Qi-Lu Cheng's work exemplifies the impact of innovative research in the pharmaceutical industry. His contributions to cancer treatment through his patented compounds are invaluable in the ongoing battle against malignant diseases.